Anzeige
Mehr »
Login
Mittwoch, 01.04.2020 Börsentäglich über 12.000 News von 624 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 910678 ISIN: US7431871067 Ticker-Symbol: PGP 
Tradegate
30.03.20
19:21 Uhr
3,260 Euro
+0,040
+1,24 %
1-Jahres-Chart
PROGENICS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
PROGENICS PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,140
3,180
19:47
3,140
3,160
19:46

Aktuelle News zur PROGENICS PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.03.BRIEF-Progenics Pharmaceuticals Reports Q4 Loss Per Share Of $0.131
13.03.PROGENICS PHARMACEUTICALS INC - 8-K, Current Report-
PROGENICS PHARMACEUTICALS Aktie jetzt für 4€ handeln
13.03.Progenics Pharmaceuticals EPS beats by $0.12, beats on revenue1
05.03.BRIEF-Progenics Pharmaceuticals - Patrick Fabbio Provided Notice To Board To Resign As CFO3
04.03.PROGENICS PHARMACEUTICALS INC - 8-K, Current Report-
20.02.Progenics up 11% on improved merger terms with Lantheus5
20.02.PROGENICS PHARMACEUTICALS INC - 8-K, Current Report2
20.02.BRIEF-Lantheus And Progenics Agree To Amended Transaction Terms4
17.02.Progenics: Ready To Decouple From Lantheus After PyL Data4
06.02.Progenics Pharmaceuticals Inc.: Progenics Pharmaceuticals Announces Presentations at the 2020 American Society of Clinical Oncology Genitourinary Cancers ...3
21.01.PROGENICS PHARMACEUTICALS INC - 8-K, Current Report7
16.01.Progenics Pharmaceuticals Inc.: Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter Meeting5
23.12.19Progenics +20% premarket on positive PyL data in prostate cancer10
19.12.19PROGENICS PHARMACEUTICALS INC - 8-K, Current Report2
25.11.19Progenics Pharmaceuticals Inc.: Progenics Pharmaceuticals Announces Presentations at the Radiological Society ...5
22.11.19Progenics Pharma taps Mims as interim CEO2
21.11.19PROGENICS PHARMACEUTICALS INC - 8-K, Current Report-
15.11.19PROGENICS PHARMACEUTICALS INC - 8-K, Current Report2
08.11.19Progenics Pharmaceuticals Inc.: Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent ...3
07.11.19PROGENICS PHARMACEUTICALS INC - 8-K, Current Report-
Seite:  Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1